A longitudinal comparison of emotional, behavioral and attention problems in autistic and typically developing children.

Autism attention problems behavioral problems emotional problems longitudinal trajectories

Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 2 1 2024
pubmed: 29 6 2023
entrez: 29 6 2023
Statut: ppublish

Résumé

Mental health problems are elevated in autistic individuals but there is limited evidence on the developmental course of problems across childhood. We compare the level and growth of anxious-depressed, behavioral and attention problems in an autistic and typically developing (TD) cohort. Latent growth curve models were applied to repeated parent-report Child Behavior Checklist data from age 2-10 years in an inception cohort of autistic children (Pathways, Autistic children showed elevated levels of mental health problems, but this was substantially reduced by accounting for IQ and sex differences between the autistic and TD samples. There was small differences in growth patterns; anxious-depressed problems were particularly elevated at preschool and attention problems at late childhood. Higher family income predicted lower base-level on all three dimensions, but steeper increase of anxious-depressed problems. Higher IQ predicted lower level of attention problems and faster decline over childhood. Female sex predicted higher level of anxious-depressed and faster decline in behavioral problems. Social-affect autism symptom severity predicted elevated level of attention problems. Autistic girls' problems were particularly elevated relative to their same-sex non-autistic peers. Autistic children, and especially girls, show elevated mental health problems compared to TD children and there are some differences in predictors. Assessment of mental health should be integrated into clinical practice for autistic children.

Sections du résumé

BACKGROUND BACKGROUND
Mental health problems are elevated in autistic individuals but there is limited evidence on the developmental course of problems across childhood. We compare the level and growth of anxious-depressed, behavioral and attention problems in an autistic and typically developing (TD) cohort.
METHODS METHODS
Latent growth curve models were applied to repeated parent-report Child Behavior Checklist data from age 2-10 years in an inception cohort of autistic children (Pathways,
RESULTS RESULTS
Autistic children showed elevated levels of mental health problems, but this was substantially reduced by accounting for IQ and sex differences between the autistic and TD samples. There was small differences in growth patterns; anxious-depressed problems were particularly elevated at preschool and attention problems at late childhood. Higher family income predicted lower base-level on all three dimensions, but steeper increase of anxious-depressed problems. Higher IQ predicted lower level of attention problems and faster decline over childhood. Female sex predicted higher level of anxious-depressed and faster decline in behavioral problems. Social-affect autism symptom severity predicted elevated level of attention problems. Autistic girls' problems were particularly elevated relative to their same-sex non-autistic peers.
CONCLUSIONS CONCLUSIONS
Autistic children, and especially girls, show elevated mental health problems compared to TD children and there are some differences in predictors. Assessment of mental health should be integrated into clinical practice for autistic children.

Identifiants

pubmed: 37381780
doi: 10.1017/S0033291723001599
pii: S0033291723001599
pmc: PMC10755241
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7707-7719

Subventions

Organisme : Medical Research Council
ID : MR/L022257/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L022257/1
Pays : United Kingdom

Références

J Am Acad Child Adolesc Psychiatry. 2013 Oct;52(10):1057-1065.e1
pubmed: 24074472
Transl Psychiatry. 2020 Jan 15;10(1):4
pubmed: 32066658
Dev Psychopathol. 2004 Spring;16(2):313-33
pubmed: 15487598
PLoS One. 2019 May 24;14(5):e0217342
pubmed: 31125387
JAMA Psychiatry. 2018 Aug 1;75(8):835-843
pubmed: 29898212
Autism. 2019 Jul;23(5):1152-1164
pubmed: 30288984
J Abnorm Child Psychol. 2010 Jan;38(1):19-31
pubmed: 19662525
Autism. 2021 Jan;25(1):90-101
pubmed: 32921150
J Autism Dev Disord. 2022 Mar;52(3):1077-1091
pubmed: 33864558
Dev Neuropsychol. 2005;28(1):459-72
pubmed: 15992251
J Am Acad Child Adolesc Psychiatry. 2015 May;54(5):369-76.e3
pubmed: 25901773
Autism. 2022 Oct;26(7):1656-1667
pubmed: 36113122
Autism Res. 2020 Dec;13(12):2038-2057
pubmed: 32978905
J Autism Dev Disord. 2012 Jul;42(7):1304-13
pubmed: 21947663
J Child Psychol Psychiatry. 2018 Jun;59(6):667-675
pubmed: 29197107
J Child Psychol Psychiatry. 2001 Jul;42(5):679-89
pubmed: 11464972
Acta Psychiatr Scand. 2021 Nov;144(5):475-486
pubmed: 34228813
J Ment Health Res Intellect Disabil. 2014 Oct 1;7(4):306-322
pubmed: 25419257
Front Integr Neurosci. 2021 Jan 28;14:594082
pubmed: 33584212
J Am Acad Child Adolesc Psychiatry. 2020 Jul;59(7):890-899.e3
pubmed: 31541676
Am J Ment Defic. 1985 Mar;89(5):485-91
pubmed: 3993694
J Autism Dev Disord. 2000 Jun;30(3):205-23
pubmed: 11055457
Behav Brain Res. 2002 Mar 10;130(1-2):3-28
pubmed: 11864714
Dev Psychopathol. 2020 Oct;32(4):1375-1389
pubmed: 31588887
Autism. 2017 Aug;21(6):646-658
pubmed: 27940569
Dev Psychol. 2010 Sep;46(5):1159-75
pubmed: 20822230
Am J Intellect Dev Disabil. 2011 Sep;116(5):381-97
pubmed: 21905806
J Child Psychol Psychiatry. 2008 May;49(5):535-42
pubmed: 18221348
Autism. 2020 May;24(4):1011-1024
pubmed: 32191121
Front Hum Neurosci. 2014 Apr 29;8:268
pubmed: 24808851
J Res Adolesc. 2016 Dec;26(4):991-1008
pubmed: 28453213
Eur Child Adolesc Psychiatry. 2015 Sep;24(9):1129-38
pubmed: 25600178
Eur Child Adolesc Psychiatry. 2019 Aug;28(8):1107-1115
pubmed: 30659384
Dev Psychopathol. 2020 Oct;32(4):1287-1302
pubmed: 32677592
J Child Psychol Psychiatry. 2019 May;60(5):497-499
pubmed: 30968422
Autism Res. 2019 Sep;12(9):1367-1375
pubmed: 31102337
J Am Acad Child Adolesc Psychiatry. 2008 Aug;47(8):921-9
pubmed: 18645422
Neurosci Biobehav Rev. 2016 Jun;65:229-63
pubmed: 27026637
Dev Psychopathol. 2017 Feb;29(1):203-214
pubmed: 26847324
J Abnorm Child Psychol. 2006 Feb;34(1):71-85
pubmed: 16565888
Am J Med Genet B Neuropsychiatr Genet. 2004 Jan 1;124B(1):41-7
pubmed: 14681911
J Am Acad Child Adolesc Psychiatry. 2016 Feb;55(2):106-13.e4
pubmed: 26802777
J Child Psychol Psychiatry. 2019 May;60(5):516-523
pubmed: 30506566
Neurosci Biobehav Rev. 2016 Dec;71:529-541
pubmed: 27629802
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Res Autism Spectr Disord. 2012 Jan;6(1):96-108
pubmed: 22059091
Autism. 2016 Jul;20(5):628-34
pubmed: 26825959
Psychiatry Res. 2019 Dec;282:112566
pubmed: 31558402
Trends Cogn Sci. 2012 Sep;16(9):454-7
pubmed: 22835639
J Autism Dev Disord. 2015 Aug;45(8):2283-94
pubmed: 25737019
J Autism Dev Disord. 2004 Aug;34(4):379-93
pubmed: 15449514
PLoS One. 2012;7(10):e45446
pubmed: 23091594
J Youth Adolesc. 2019 Apr;48(4):815-827
pubmed: 30671716
J Autism Dev Disord. 2009 Jul;39(7):986-95
pubmed: 19263208
Child Dev. 2004 Sep-Oct;75(5):1523-37
pubmed: 15369529

Auteurs

N Wright (N)

Department of Psychology, Manchester Metropolitan University, Manchester, UK.

V Courchesne (V)

Centre for Addiction and Mental Health, University of Toronto, Toronto, Canada.

A Pickles (A)

Department of Biostatistics & Health Informatics, King's College London, London, UK.

R Bedford (R)

Department of Psychology, University of Bath, Bath, UK.

E Duku (E)

McMaster University, Hamilton, Canada.

C M Kerns (CM)

Department of Psychology, University of British Columbia, Vancouver, Canada.

T Bennett (T)

McMaster University, Hamilton, Canada.

S Georgiades (S)

McMaster University, Hamilton, Canada.

J Hill (J)

School of Psychology & Clinical Language Sciences, University of Reading, Reading, UK.

A Richard (A)

IWK Health Centre, Autism Research Centre, Halifax, Canada.

H Sharp (H)

Department of Primary Care and Mental Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.

I M Smith (IM)

Dalhousie University and IWK Health, Halifax, Canada.

T Vaillancourt (T)

University of Ottawa, Ottawa, Canada.

A Zaidman-Zait (A)

Tel Aviv University, Tel Aviv, Israel.

L Zwaigenbaum (L)

University of Alberta, Alberta, Canada.

P Szatmari (P)

Centre for Addiction and Mental Health, University of Toronto, Toronto, Canada.

M Elsabbagh (M)

Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH